Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial

Jeffrey R. Infante, Leslie Anne Fecher, Gerald Steven Falchook et al. · The Lancet Oncology · 2012

Cited by 552 works. doi:10.1016/s1470-2045(12)70270-x

Authors

References